Lessee, Operating Lease, Liability, to be Paid of InMed Pharmaceuticals Inc. from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
InMed Pharmaceuticals Inc. quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 30 Sep 2020 to 30 Sep 2025.
  • InMed Pharmaceuticals Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 30 Sep 2025 was $668,267, a 41% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

InMed Pharmaceuticals Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $668,267 -$473,853 -41% 30 Sep 2025 10-Q 06 Nov 2025 2026 Q1
Q2 2025 $788,317 -$256,554 -25% 30 Jun 2025 10-K 23 Sep 2025 2025 FY
Q1 2025 $898,599 31 Mar 2025 10-Q 12 May 2025 2025 Q3
Q4 2024 $1,012,565 -$287,343 -22% 31 Dec 2024 10-Q 12 Feb 2025 2025 Q2
Q3 2024 $1,142,120 +$844,361 +284% 30 Sep 2024 10-Q 14 Nov 2024 2025 Q1
Q2 2024 $1,044,871 +$651,141 +165% 30 Jun 2024 10-K 30 Sep 2024 2024 FY
Q4 2023 $1,299,908 +$690,358 +113% 31 Dec 2023 10-Q 13 Feb 2024 2024 Q2
Q3 2023 $297,759 -$241,031 -45% 30 Sep 2023 10-Q 14 Nov 2023 2024 Q1
Q2 2023 $393,730 30 Jun 2023 10-K 29 Sep 2023 2023 FY
Q1 2023 $501,376 31 Mar 2023 10-Q 15 May 2023 2023 Q3
Q4 2022 $609,550 31 Dec 2022 10-Q 17 Feb 2023 2023 Q2
Q3 2022 $538,790 30 Sep 2022 10-Q 14 Nov 2022 2023 Q1
Q2 2021 $312,442 30 Jun 2021 10-K 24 Sep 2021 2021 FY
Q1 2021 $588,759 31 Mar 2021 10-Q 13 May 2021 2021 Q3
Q4 2020 $581,519 31 Dec 2020 10-Q 11 Feb 2021 2021 Q2
Q3 2020 $363,322 30 Sep 2020 10-Q 17 Dec 2020 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.